• SENSEX 78,553.20
    1,508.91 (+1.96%)
  • BANKNIFTY 54,290.20
    1,172.45 (+2.21%)
  • Avenue Super.
    4,395.00 5,484.00(%)
  • Infosys
    1,429.40 2,006.80(%)
  • Waaree Renewab.
    1,170.00 3,037.75(%)
  • Mazagon Dock
    2,695.15 1,046.00(%)
  • ICICI Bank
    1,408.60 1,408.60(%)
  • HDFC Bank
    1,919.35 1,919.35(%)
  • Nip. India Nifty
    266.74 292.58(%)
  • Tata Motors
    626.90 1,179.05(%)
  • KFin Technolog.
    1,145.00 1,640.00(%)
  • Coforge
    6,668.00 10,017.95(%)
  • Angel One
    2,385.85 3,502.60(%)
  • Wipro
    232.20 208.40(%)
  • Glenmark Pharma.
    1,336.95 985.60(%)
  • St Bk of India
    801.00 912.10(%)
  • IndusInd Bank
    800.85 1,550.00(%)
  • SpiceJet
    51.29 79.90(%)
  • Bharti Airtel
    1,897.95 1,897.95(%)
  • Suzlon Energy
    55.71 86.04(%)
  • Reliance Industr
    1,279.45 1,608.95(%)
  • NBCC
    100.00 139.83(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medicamen Organics Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92885.0
  • ISIN : INE0PE401018
28.95 1 (4.89%)
  • As on 19 Apr 2025 (EOD)

  • Today’s Low

    27.60

  • Today’s High

    28.95

  • Open

    27.60

  • Perv Close

    27.60

  • 52W Low

    19.60

  • 52W High

    159.40

Key Indicators

  • P/E(TTM)

    14.12

  • Mar.Cap (₹Cr.)

    33.87

  • Div & Yield %

    0.00

  • Book Value(₹)

    21.99

  • Debt-Equity Ratio

    4.89

  • AGM Date

    17-Apr-2025

  • EPS

    2.05

  • P/E Ratio

    14.12

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    33.87

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    11.70

  • BV (₹)

    22.00

  • Sales( ₹ in Cr.)

    25.27

  • NP (in Cr.)

    2.40

  • NP Var(%)

    148.0

  • Div%

    0.0

  • CPS (₹)

    2.70

  • EPS (₹)

    2.10

  • Traded Value (₹ in Lakhs)

    33.87

  • 52 Week High

    159.40

  • 52 Week Low

    19.60

  • Price BSE

    0.0

  • Price NSE

    29.00

  • Market Capital( in Cr.)

    33.87

  • P/C Ratio

    10.90

  • P/E Ratio

    14.10

  • Price Vs.BV

    2.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 25.27 22.15 20.98 25.05 31.49 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 25.27 22.15 20.98 25.05 31.49 -
Other Income 0.02 0.82 0.21 0.01 0.09 -
Stock Adjustments 1.47 0.60 0.71 -0.55 0.19 -
Total Income 26.76 23.57 21.90 24.51 31.77 -
EXPENDITURE :            
Raw Materials 10.64 10.56 14.12 15.31 15.91 -
Power and Fuel Cost 0.97 0.82 0.72 0.91 1.20 -
Employee Cost 3.02 2.87 2.49 2.33 2.58 -
Other Manufacturing Expenses 5.69 5.06 1.56 2.05 8.84 -
Selling and Administration Expenses 1.41 1.47 1.47 1.80 1.59 -
Miscellaneous Expenses 0.26 0.10 0.14 0.47 0.20 -
Employee Benefit Expenses 3.02 2.87 2.49 2.33 2.58 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 22.01 20.88 20.49 22.86 30.33 -
Operating Profit 4.76 2.68 1.41 1.65 1.44 -
Interest 0.65 0.61 0.47 0.48 0.46 -
Gross Profit 4.11 2.07 0.94 1.17 0.98 -
Depreciation 0.72 0.71 0.68 0.68 0.77 -
Profit Before Tax 3.39 1.36 0.26 0.49 0.21 -
Current Tax 0.96 0.34 0.10 0.12 0.04 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.02 0.05 0.06 0.08 0.06 -
Reported Net Profit 2.40 0.97 0.09 0.30 0.10 -
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -
Adjusted Net Profit 2.40 0.97 0.09 0.30 0.10 -
Adjustment below Net Profit 0.00 0.00 0.00 0.06 0.01 -
P & L Balance brought forward 2.07 1.10 0.55 0.19 0.09 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 4.47 2.07 0.64 0.55 0.19 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 2.80 1.62 0.15 0.50 0.17 -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 17.66 14.97 12.60 12.45 11.85 -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    59.69%

  • Public Share Holding

    40.31%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,983,900 59.69 6,983,900 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,983,900 59.69 6,983,900 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,000 0.14 16,000 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 8,000 0.07 8,000 1
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 432,000 3.69 432,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 456,000 3.90 456,000 4
2] Non Institution
Bodies Corporate 404,000 3.45 404,000 14
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 212,000 1.81 212,000 15
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 336,000 2.87 336,000 26
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,596,000 13.64 1,596,000 16
Individuals holding nominal share capital up to Rs. 1 lakh 1,712,100 14.63 1,712,100 299
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,260,100 36.41 4,260,100 370
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,700,000 100.00 11,700,000 379

Company Background

Medicamen Organics LtdPharmaceuticals - Indian - Formulations

  • Medicamen Organics Ltd
  • BSE Code : 92885.0
  • ISIN : INE0PE401018

  • Incorporation Year

    1995

  • Registered Office

    10 Community Centre No 2
    Ashok Vihar Phase II, New Delhi,
    Delhi-110052

  • Telephone

    +91 98182 22845

  • FAX

  • Chairman

    B K Gupta

  • Managing Director

    B K Gupta

  • Company Secretary

    Varsha Bansal

  • Auditor

    N C Raj & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Medicamen Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medicamen 28.95 25.29 25.27 14.12 16.44
Abbott India 30,681.95 6,097.18 5,848.91 48.86 44.71
Astrazeneca Phar 8,749.25 1,330.33 1,295.53 225.55 33.26
P & G Health Ltd 5,229.25 1,166.89 1,151.26 36.69 39.76
Glaxosmi. Pharma 2,909.25 3,530.73 3,407.25 57.85 44.44
Cipla 1,515.45 17,645.00 16,574.34 25.98 20.10
Amrutanjan Healt 674.85 437.58 421.23 39.56 20.84
Guj. Themis Bio. 316.15 174.19 169.82 65.46 44.82
Fermenta Biotec. 274.60 315.24 307.09 26.03 4.10
Bliss GVS Pharma 124.90 638.96 605.46 28.58 11.19
Ambalal Sarabhai 39.16 11.70 3.81 16.74 1.92